Literature DB >> 8370709

Morphological and functional polymorphism within clonal thyroid nodules.

S Aeschimann1, P A Kopp, E T Kimura, J Zbaeren, A Tobler, M F Fey, H Studer.   

Abstract

Thirty-nine thyroid nodules, removed because of recent growth, were analyzed morphologically by serial histological sections for the classical histomorphological hallmarks of follicular cell replication and for immunohistochemically demonstrable overexpression of the growth-associated ras-gene product p21ras. Clonal analysis was performed using the highly informative probe M27 beta that detects polymorphisms on the locus DXS255 of the X-chromosome. Twenty-four nodules were of clonal and 15 nodules were of poly-clonal origin. Only 3 out of the 24 clonal nodules were histomorphologically uniform. In all others, the structural hallmarks of active growth and the P21ras growth-marker expression were remarkably heterogeneous throughout the tumors. There were no histomorphological characteristics distinguishing these clonal tumors from polyclonal nodules. Even if a clonal thyroid tumor may be originally homogeneous in respect to the parameters studied here, mechanisms must exist that create wide heterogeneity of growth and of morphogenetic potential among the individual follicular cells during further expansion of the nodule. Thus, clonal nodules are much more common in nodular goiters than hitherto assumed on grounds of the classical morphological criteria. The diagnosis of a true monoclonal nodule can no longer rely on morphological and functional criteria alone but requires molecular or cytogenetic analysis of clonality.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370709     DOI: 10.1210/jcem.77.3.8370709

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

Review 2.  Thyroglobulin autoregulation of thyroid-specific gene expression and follicular function.

Authors:  K Suzuki; M Nakazato; L Ulianich; A Mori-Aoki; E Moriyama; H K Chung; M Pietrarelli; A Grassadonia; H Matoba; L D Kohn
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

3.  Clonality of Endocrine Proliferative Lesions: A Critical Reappraisal.

Authors:  Ronald A. DeLellis; Arthur S. Tischler
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

4.  Clonality in Thyroid Nodules: The Hyperplasia-Neoplasia Sequence.

Authors:  Zubair W. Baloch; Virginia A. LiVolsi
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

Review 5.  The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid.

Authors:  Sylvia L Asa
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

6.  The association of warthin tumor with salivary ductal inclusions in intra and periparotid lymph nodes.

Authors:  W Cope; C Naugler; S M Taylor; J Trites; R D Hart; M J Bullock
Journal:  Head Neck Pathol       Date:  2013-07-19

Review 7.  Oncocytes, oxyphils, Hürthle, and Askanazy cells: morphological and molecular features of oncocytic thyroid nodules.

Authors:  Ozgur Mete; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2010-03       Impact factor: 3.943

8.  Clonality as expression of distinctive cell kinetics patterns in nodular hyperplasias and adenomas of the adrenal cortex.

Authors:  S J Díaz-Cano; M de Miguel; A Blanes; R Tashjian; H Galera; H J Wolfe
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

9.  Thyroid nodules in recurrent multinodular goiters are predominantly polyclonal.

Authors:  P Harrer; M Broecker; A Zint; H Schatz; V Zumtobel; M Derwahl
Journal:  J Endocrinol Invest       Date:  1998-06       Impact factor: 4.256

10.  Clonality of the parathyroid nodules with uremic parathyroid hyperplasia.

Authors:  L Shan; K Kakudo; M Nakamura; Y Nakamura; T Yokoi; J Ishimoto; K Kawahara; H Takami
Journal:  Pathol Oncol Res       Date:  1997-09       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.